251 related articles for article (PubMed ID: 16493609)
41. Antithrombin III assay using thrombin in disseminated intravascular coagulation (DIC), other thromboembolic disorders and hepatic diseases.
Saxena V; Mishra DK; Subramanya H; Satyanarayana S; Sharma A
Indian J Pathol Microbiol; 2004 Apr; 47(2):210-2. PubMed ID: 16295470
[TBL] [Abstract][Full Text] [Related]
42. [Association of acute leukemia with disseminated intravascular coagulation in adults. Analysis of 14 cases].
Zuazu I; Canals C; Sempere A; Martín S; Brunet S; Puig J; Fontcuberta J; Grau E
Med Clin (Barc); 1989 Oct; 93(12):441-4. PubMed ID: 2607808
[TBL] [Abstract][Full Text] [Related]
43. Increased proteolysis of antithrombin III Vicenza during disseminated intravascular coagulation in acute leukemia.
Castaman G; Ruggeri M; Rodeghiero F
Thromb Res; 1989 Sep; 55(5):661-4. PubMed ID: 2814948
[No Abstract] [Full Text] [Related]
44. Evidence of a hypercoagulable state in patients with acute lymphoblastic leukemia treated with low dose of E. coli L-asparaginase: a GIMEMA study.
Leone G; Gugliotta L; Mazzucconi MG; De Stefano V; Belmonte MM; Dragoni F; Specchia G; Centra A; Gamba G; Camera A
Thromb Haemost; 1993 Jan; 69(1):12-5. PubMed ID: 8446931
[TBL] [Abstract][Full Text] [Related]
45. Hypercoagulability during induction therapy of acute lymphoblastic leukemia is of scarce clinical relevance. Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto.
de Stefano V; Gugliotta L; Mazzucconi MG; Leone G; Mandelli F
Blood; 1993 May; 81(9):2468-9. PubMed ID: 7683221
[No Abstract] [Full Text] [Related]
46. [Cerebral sinovenous thrombosis and acquired antithrombin, protein C and S deficiency during chemotherapy in a young man: report of a case].
Munoz VT; Triffet A; Cauchie P; Brohée D
Rev Med Brux; 2008; 29(6):535-9. PubMed ID: 19202708
[TBL] [Abstract][Full Text] [Related]
47. [Studies on antithrombin III. II. The role for antithrombin III (ATIII) in the control of disseminated intravascular coagulation (DIC). (The effect of the administration of ATIII concentrates in experimental DIC and in clinical DIC) (author's transl)].
Takahashi K
Nihon Ketsueki Gakkai Zasshi; 1980 Oct; 43(5):889-97. PubMed ID: 6940410
[No Abstract] [Full Text] [Related]
48. Alpha-2 antiplasmin in acute nonlymphoblastic leukemia.
Cofrancesco E; Pogliani E; Salvatore M; Moreo G; Boschetti C; Cortellaro M
Acta Haematol; 1989; 81(3):122-5. PubMed ID: 2469277
[TBL] [Abstract][Full Text] [Related]
49. Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96.
Ribera JM; Oriol A; Sanz MA; Tormo M; Fernández-Abellán P; del Potro E; Abella E; Bueno J; Parody R; Bastida P; Grande C; Heras I; Bethencourt C; Feliu E; Ortega JJ
J Clin Oncol; 2008 Apr; 26(11):1843-9. PubMed ID: 18398150
[TBL] [Abstract][Full Text] [Related]
50. Correlation between high vascular endothelial growth factor-A serum levels and treatment outcome in patients with standard-risk acute lymphoblastic leukemia: a report from Children's Oncology Group Study CCG-1962.
Avramis IA; Panosyan EH; Dorey F; Holcenberg JS; Avramis VI;
Clin Cancer Res; 2006 Dec; 12(23):6978-84. PubMed ID: 17145817
[TBL] [Abstract][Full Text] [Related]
51. [Acute myelogenous leukemia associated with disseminated intravascular coagulation and acute myocardial infarction at relapse].
Yamaguchi M; Murata R; Mizutani T; Kawamura Y; Ueda M
Rinsho Ketsueki; 2001 Sep; 42(9):716-8. PubMed ID: 11680986
[TBL] [Abstract][Full Text] [Related]
52. Comparison of low-molecular-weight heparin and antithrombin versus antithrombin alone for the prevention of symptomatic venous thromboembolism in children with acute lymphoblastic leukemia.
Meister B; Kropshofer G; Klein-Franke A; Strasak AM; Hager J; Streif W
Pediatr Blood Cancer; 2008 Feb; 50(2):298-303. PubMed ID: 17443678
[TBL] [Abstract][Full Text] [Related]
53. Successful management of cerebral and pulmonary mucormycosis with liposomal amphotericin B in a 28-year-old woman with acute lymphoblastic leukemia.
Salonen JH
Acta Biomed; 2006; 77 Suppl 2():28-31. PubMed ID: 16918065
[TBL] [Abstract][Full Text] [Related]
54. Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy.
Aricò M; Valsecchi MG; Rizzari C; Barisone E; Biondi A; Casale F; Locatelli F; Lo Nigro L; Luciani M; Messina C; Micalizzi C; Parasole R; Pession A; Santoro N; Testi AM; Silvestri D; Basso G; Masera G; Conter V
J Clin Oncol; 2008 Jan; 26(2):283-9. PubMed ID: 18182669
[TBL] [Abstract][Full Text] [Related]
55. Selecting drug regimens in human leukemia.
Hall TC
Natl Cancer Inst Monogr; 1971 Dec; 34():145-51. PubMed ID: 5291098
[No Abstract] [Full Text] [Related]
56. Antithrombin III infusion suppresses the hypercoagulable state in adult acute lymphoblastic leukaemia patients treated with a low dose of Escherichia coli L-asparaginase. A GIMEMA study.
Mazzucconi MG; Gugliotta L; Leone G; Dragoni F; Belmonte MM; De Stefano V; Chistolini A; Tura S; Mandelli F
Blood Coagul Fibrinolysis; 1994 Feb; 5(1):23-8. PubMed ID: 7514043
[TBL] [Abstract][Full Text] [Related]
57. Diagnosis and prognosis of overt disseminated intravascular coagulation in a general hospital -- meaning of the ISTH score system, fibrin monomers, and lipoprotein-C-reactive protein complex formation.
Cauchie P; Cauchie Ch; Boudjeltia KZ; Carlier E; Deschepper N; Govaerts D; Migaud-Fressart M; Woodhams B; Brohée D
Am J Hematol; 2006 Jun; 81(6):414-9. PubMed ID: 16680742
[TBL] [Abstract][Full Text] [Related]
58. Fresh frozen plasma has no beneficial effect on the hemostatic system in children receiving L-asparaginase.
Halton JM; Mitchell LG; Vegh P; Eves M; Andrew ME
Am J Hematol; 1994 Nov; 47(3):157-61. PubMed ID: 7524313
[TBL] [Abstract][Full Text] [Related]
59. Resistance to activated protein C: arterial thrombosis associated with autoimmune features.
Yossepowitch O; Chajek-Shaul T; Rubinow A; Haviv YS; Safadi R
Eur J Med Res; 1997 Aug; 2(8):355-7. PubMed ID: 9262489
[TBL] [Abstract][Full Text] [Related]
60. [Coagulation inhibitors in patients with neoplasms].
Páramo JA; Cuesta B; Hernández M; Fernández J; Paloma MJ; Rifón J; Rocha E
Med Clin (Barc); 1989 Feb; 92(5):164-6. PubMed ID: 2524631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
